ENTITY

Physiomics (PYC LN)

34
Analysis
Industrials • United Kingdom
Physiomics is a data-driven consultancy that provides Model-Informed Drug Development (MIDD), Biostatistics, Statistical Programming, and Bioinformatics solutions to biopharmaceutical companies and research institutes. The company utilizes its proprietary Virtual Tumour technology platform to optimize the design of cancer clinical trials and predict the effects of treatments. Physiomics was founded in 2001 and is headquartered in Abingdon, United Kingdom.
more
bullish•Physiomics
•06 Oct 2025 20:00•Issuer-paid

Hybridan Research: Physiomics plc: Building Lasting Traction

The progress made by the operational expansion is evidenced by these finals to June 2025, which report a 46% increase in Revenue to £0.83m. The...

Logo
Hybridan
234 Views
Share
•13 Aug 2025 18:05•Issuer-paid

Water Intelligence PLC - Hybridan Small Cap Feast: 06/08/2025

AudioBoom Group 347.5p £62.4m (BOOM.L) The global podcast company, announced key milestones and data points connected to the growth of its podcast...

Logo
Hybridan
249 Views
Share
•23 Jul 2025 11:56•Issuer-paid

Hybridan Small Cap Feast: 14/07/2025

Beeks continued to achieve a positive free cash flow position over the year with unaudited net cash of £6.96m at the period end (30 June 2024 net...

Logo
Hybridan
216 Views
Share
bullish•Physiomics
•22 Jul 2025 17:01•Issuer-paid

Hybridan Research: Physiomics plc

Physiomics PLC (PYC) announced a trading update. We have published research on this which is attached and a snapshot of the research is below.

Logo
Hybridan
212 Views
Share
•24 Jun 2025 07:11•Issuer-paid

Duplicate of Hybridan Small Cap Feast: 12/06/2025

A routine thematic compliance inspection commenced earlier this year in the BVI, which was disclosed in the Company's Registration Document,...

Logo
Hybridan
288 Views
Share
x